Now showing items 1-1 of 1

    • Preclinical effects of APOE [epsilon]4 on cerebrospinal fluid Aß42 concentrations 

      Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H (Springer Nature, 2017)
      Background From earlier studies it is known that the APOE ε2/ε3/ε4 polymorphism modulates the concentrations of cerebrospinal fluid (CSF) beta-amyloid1–42 (Aβ42) in patients with cognitive decline due to Alzheimer’s disease ...
      info:eu-repo/semantics/article